摘要 |
The present invention is related to the preparation and pharmaceutical use of novel haloallylamine derivatives as SSAO/VAP-1 inhibitors having the structure of Formula I, as defined in the specification:(I). The invention also relates to methods of using invention compounds, or pharmaceutically acceptable salt or derivatives thereof, for the treatment of a variety of indications, e.g., inflammatory diseases. |
申请人 |
PHARMAXIS LTD.;MCDONALD, IAN, ALEXANDER;TURNER, CRAIG, IVAN;DEODHAR, MANDAR;FOOT, JONATHAN, STUART |
发明人 |
MCDONALD, IAN, ALEXANDER;TURNER, CRAIG, IVAN;DEODHAR, MANDAR;FOOT, JONATHAN, STUART |